Adult- PO- Initial- The recommended starting dose is 1-2 mg once daily, with food. Maximum: 2mg/day. Caution should be exercised in patients with history of liver and kidney disease, ketoacidosis, ...
DUBAI, United Arab Emirates--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a Phase 3 clinical study which showed that reductions ...
STOCKHOLM--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a randomized, double blind Phase 3 clinical study, which demonstrated ...
Long-term use of glimepiride may improve survival and reduce hospitalizations in hospitalized patients with concomitant type 2 diabetes and chronic HF, researchers reported. In addition, high-dose ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes experienced no difference in cardiovascular autonomic neuropathy measures or B-type ...
Rosiglitazone (as maleate), glimepiride; 4mg/1mg, 4mg/2mg, 4mg/4mg, 8mg/2mg, 8mg/4mg; tabs. ≥18yrs: Take once daily with first meal of the day. Drug-naive: 4mg/1mg. Previously on thiazolidinedione ...
Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback